Tyme Technologies Stock News

Tyme Technologies, Inc. (NASDAQ:TYME) insider Steve Hoffman sold 78,125 shares of the companys stock in a transaction on Thursday, December 2nd. The shares were sold at an average price of $0.72, for a total transaction of $56,250.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Steve Hoffman []

Tyme Technologies recently reported their Q2 earnings that revealed the company only burned roughly $5M in cash with about $97M left in the bank. The small-cap sell-off has pushed the share price to f

Tyme Technologies Inc. (NASDAQ:TYME) price closed lower on Friday, December 03, dropping -8.86% below its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy

Northern Trust Corp trimmed its holdings in shares of Tyme Technologies, Inc. (NASDAQ:TYME) by 77.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 185,608 shares of the companys stock after selling 627,061 shares during the period. Northern Trust Corp owned approximately 0.11% of Tyme Technologies [] The post Tyme Technologies, Inc. (NASDAQ:TYME) Shares Sold by Northern Trust Corp appeared first on ETF Daily News .

Twitter, Inc. (TWTR) with the stream of -1.36% also noticed, India Tyme Technologies, Inc. (TYME) encountered a rapid change of -8.86% in the last hour of Fridays trading session. Twitter, The post Eye-catching Shares: Twitter, Inc. (NYSE:TWTR), Tyme Technologies, Inc. (NASDAQ:TYME) appeared first on Stocks Equity .

Millennium Management LLC raised its stake in Tyme Technologies, Inc. (NASDAQ:TYME) by 1,209.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,122,578 shares of the companys stock after purchasing an additional 1,960,455 shares during the period. Millennium Management LLC owned []

Tyme Technologies, Inc. (TYME) with the stream of -5.82% also noticed, India Ault Global Holdings, Inc. (DPW) encountered a rapid change of 0.00% in the last hour of Mondays trading The post Latest Tally Of Analyst Opinions: Tyme Technologies, Inc. (NASDAQ:TYME), Ault Global Holdings, Inc. (AMEX:DPW) appeared first on Stocks Equity .

Cocrystal Pharma, Inc. (COCP) with the stream of 18.57% also noticed, India Tyme Technologies, Inc. (TYME) encountered a rapid change of -2.32% in the last hour of trading session. Cocrystal The post Volume Buzz: Cocrystal Pharma, Inc. (NASDAQ:COCP), Tyme Technologies, Inc. (NASDAQ:TYME) appeared first on Stocks Equity .

Tyme Technologies, Inc. (TYME) with the stream of -2.32% also noticed, India PEDEVCO Corp. (PED) encountered a rapid change of -0.87% in the last hour of Fridays trading session. Tyme The post Bright Trending Stock: Tyme Technologies, Inc. (NASDAQ:TYME), PEDEVCO Corp. (AMEX:PED) appeared first on Stocks Equity .

Tyme Technologies Inc. (NASDAQ:TYME) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 6.64% to the previous days close as strong demand from buyers drove the stock to $0.80. Actively observing the price movement in the last trading, the stock closed the session at $0.75, falling within a range of $0.73 Thinking Of Buying Tyme Technologies Inc. (NASDAQ: TYME) Stock? Here Is What You Should Know Read More »

Geode Capital Management LLC lessened its position in shares of Tyme Technologies, Inc. (NASDAQ:TYME) by 35.5% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 828,948 shares of the companys stock after selling 455,682 shares during the quarter. Geode Capital Management LLC owned about 0.48% []

Tyme Technologies, Inc. (TYME) CEO Richie Cunningham on Q2 2021 Results - Earnings Call Transcript

BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announ

BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™),